Doug Hampton MUNICH, May 23, 2023 /PRNewswire/ — Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both sexes and across all age groups studied, indicating its potential as a supplementary tool … Read more
ESOC 2023: La herramienta de inteligencia artificial supera a los gestores de llamadas de emergencia humanos en la identificación de accidentes cerebrovasculares, según muestra un nuevo estudio MUNICH, 23 de mayo de 2023 /PRNewswire/ — Investigadores de Dinamarca han desarrollado un nuevo marco de inteligencia artificial (IA) para abordar la cantidad de infartos que no son … Read more
DUBLIN, May 23, 2023 /PRNewswire/ — The “Cell Therapy Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War” report has been added to ResearchAndMarkets.com’s offering. The global cell therapy market is expected to grow at a CAGR of around 18.7% during 2023-2030. Companies Mentioned AlloSource Holostem Terapie … Read more
MÜNCHEN, 23. Mai 2023 /PRNewswire/ — Forscher aus Dänemark haben ein neues System für künstliche Intelligenz (KI) entwickelt, um die Zahl der Schlaganfälle zu verringern, die von menschlichen Notrufmitarbeitern unerkannt bleiben. Das System übertraf bei der Erkennung von Schlaganfällen bei beiden Geschlechtern und in allen untersuchten Altersgruppen die Leistung der Notrufabwickler, was darauf hindeutet, dass es … Read more
MUNICH, May 23, 2023 /PRNewswire/ — Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both sexes and across all age groups studied, indicating its potential as a supplementary tool … Read more
– Preclinical and early research gene therapy programs discontinued –– Expected reductions of approximately 15% in residual 2023 OPEX – SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the discontinuation of preclinical and early research programs in gene therapy as part of a strategic portfolio prioritization. PTC will continue … Read more
SILVER SPRING, Md., May 23, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex, for patients 18 years of age and older. According … Read more
CAMBRIDGE, Mass., May 23, 2023 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the SVB Securities Biopharma Company Connect event, taking place virtually May 24th– 25th, 2023. Myeloid management will participate in virtual one-on-one meetings with investors during the event. About Myeloid Therapeutics Myeloid Therapeutics is … Read more
SÃO PAULO, May 23, 2023 /PRNewswire/ — On May 16, 2023, Zenvia Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s Class A common shares (the “Securities”) for the 30 previous consecutive business … Read more
CHARLOTTE, N.C., May 23, 2023 /PRNewswire/ — Vincent E. Voci, MD, is being recognized by Continental Who’s Who as a Most Trusted Plastic Surgeon 2023 for his contributions to the field of Plastic Surgery. Vincent E. Voci, MD Dr. Voci began his educational journey at Massachusetts at Amherst and the University of Louisville School of … Read more